B. Riley Securities, a full-service and research-driven investment bank, served as exclusive financial advisor in connection with the sale of the PoNS (Portable Neuromodulation Stimulator) System to Bioness Medical.
The acquisition expands Bioness Medical’s platform into central neuromodulation, complementing a portfolio that includes the L300 Go, H200 Wireless and Vector Gait & Safety System.
B. Riley Securities acted as exclusive financial advisor in connection with this transaction. The B. Riley deal team was led by Thomas McGlynn and included Elise Melconian, Noah Rich and Hughes Raiford.
